From: The impact of community-delivered models of malaria control and elimination: a systematic review
Author | Country | Malaria transmission | Design | Model | Malaria (M) or malaria plus (M+) | Malaria intervention delivered |
---|---|---|---|---|---|---|
Linn et al. [36] | Myanmar | Endemica | Retrospective cohort | tCHW | M | Parasitological dx + Tx + referral + BCC |
Alonso et al. [57] | Gambia | Holo-endemica | Quasi-experiment with control | tCHW | M | ITN + parasitological dx + Tx + referral + BCC |
Delacollette et al. [40] | Zaire (Congo) | Meso-endemica | Quasi-experiment with control | tCHW | M | ITN + chemoprohylaxis |
Greenwood et al. [41] | Gambia | Seasonala | Quasi-experiment with control | tCHW | M | IPTc |
Hamainza et al. [46] | Zambia | Perenniala | Quasi-experiment with control | tCHW | M | ITN + parasitological dx + Tx + referral |
Linn et al. [44] | Senegal | Pf API ≥ 0.1/1000 pab | Quasi-experiment with control | tCHW | M | Parasitological dx + Tx + referral + BCC |
Littrell et al. [35] | Cameroon | Endemic and perenniala | Quasi-experiment with control | tCHW | M | Parasitological dx + Tx + referral |
Mbonye et al. [56] | Uganda | Hyper-endemica | Quasi-experiment with control | tCHW | M | Presumptive dx + Tx + referral |
Mbonye et al. [32] | Uganda | Hyper-endemica | Quasi-experiment with control | tCHW | M | Presumptive dx + Tx + referral |
Msyamboza [47] | Malawi | Pf API ≥ 0.1/1000 pab | Quasi-experiment with control | tCHW | M | ITN + IRS + parasitological dx + Tx + referral |
Ndyomugyenyi et al. [58] | Uganda | Pf API ≥ 0.1/1000 pab | Quasi-experiment with control | tCHW | M | Presumptive dx + Tx + referral |
Tiono et al. [45] | Burkina Faso | Seasonala | Quasi-experiment with control | tCHW | M | Parasitological dx + Tx |
Das et al. [26] | India | API > 5/1000 paa | Cluster randomized trial | tCHW | M | Presumptive dx + Tx + chemoprophylaxis |
Eriksen et al. [49] | Tanzania | Holo-endemica | Cluster randomized trial | tCHW | M | IPTp + BCC |
Kweku et al. [34] | Ghana | Pf API ≥ 0.1 per 1000 pab | Cluster randomized trial | tCHW | M | Presumptive dx + Tx + referral + BCC |
Lemma et al. [43] | Ethiopia | Hypo-endemica | Cluster randomized trial | tCHW | M | ITN + BCC |
Ohnmar et al. [30] | Myanmar | Endemica | Cluster randomized trial | tCHW | M | Parasitological dx + Tx + referral |
Patouillard et al. [33] | Ghana | Seasonala | Cluster randomized trial | tCHW | M | ITN + presumptive dx + Tx + referral + BCC |
Abegunde et al. [27] | Nigeria | High perenniala | Case–control study | iCCM | M+c | ITN + parasitological dx + Tx + referral + BCC + IPTp |
Brenner et al. [28] | Uganda | Pf API ≥ 0.1 per 1000 pab | Quasi-experiment with control | iCCM | M+d | Parasitological dx + Tx + referral + BCC |
Mubiru et al. [38] | Uganda | Pf API ≥ 0.1 per 1000 pab | Quasi-experiment with control | iCCM | M+d | Parasitological dx + Tx + referral + BCC |
Nsungwa-Sabiiti et al. [37] | Uganda | Holo-endemic to hyper-endemica | Quasi-experiment with control | HMM | M+d | Parasitological dx + Tx + referral + BCC |
Thiam et al. [42] | Senegal | Pf API ≥ 0.1 per 1000 pab | Quasi-experiment with control | HMM | M+d | Presumptive dx + Tx + referral + BCC |
Tobin-West et al. [31] | Nigeria | Pf API ≥ 0.1 per 1000 pab | Quasi-experiment with control | HMM | M+e | Parasitological dx + Tx + referral + BCC |
Chinbuah et al. [48] | Ghana, Guinea | Perenniala | Cluster randomized trial | HMM | M+f | Presumptive dx + Tx + referral + BCC |
Kidane and Morrow [59] | Ethiopia | Hyper-endemica | Cluster randomized trial | HMM | M | Presumptive dx + Tx + referral + BCC |
Kouyaté et al. [39] | Burkina Faso | Holo-endemica | Cluster randomized trial | HMM | M | Parasitological dx + Tx + referral + BCC |
The CDI Study Group [29] | Cameroon, Nigeria and Uganda | Pf API ≥ 0.1 per 1000 pab | Cluster randomized trial | HMM | M+g | ITN, presumptive dx + Tx |